With the emergence of generative artificial intelligence models like ChatGPT, new demands for AI in healthcare seem to only grow its advocacy base.
The second annual MIT-MGB AI Cures Conference, hosted by the Abdul Latif Jameel Health Machine Learning Clinic (Jameer Clinic) on April 24, nearly doubled this year’s attendance and saw an increase in computer science Over 500 participants from various backgrounds gathered. , medicine, pharmaceuticals, policy.
In contrast to Boston’s cloudy sky that morning, many of the speakers were optimistic about AI in medicine, repeating two key ideas throughout the day. That is, AI has the potential, and will, to build a more equitable healthcare system. Clinicians won’t be replaced anytime soon, but clinicians who know how to use AI will eventually be replaced by clinicians who aren’t incorporating AI into their daily practice.
“Working with government partners, especially at the intersection of policy and innovation, is critical to our work,” MIT Rector Cynthia Bernhardt said in her opening address to the audience. It leaves great hope for the future of human health. ”
Anne Krivanski, president and CEO of General Brigham, Massachusetts (MGB), reflected similar optimism. If this group cannot come together to impact healthcare in a meaningful way, we have to ask ourselves why we are here… Now is the time to rethink healthcare. is. Professor Krivanski draws attention to the work of his Jameel Clinic AI faculty chair, AI Cures co-chair, MIT professor Regina Balziray and director of his MGB Center for Early Cancer Detection and Innovation Lesia Squist. collected. His work on lung cancer risk assessment, and continued collaboration between MIT and his MGB, may have fruitful implications for the future of AI in medicine.
“Will AI solve all of our sick health systems?” asked newly appointed Massachusetts Secretary of Health and Human Services Kate Walsh. “I don’t think so, but I think it’s a great place to start.” Walsh stressed that the pandemic is a wake-up call for the health system, especially to establish more equitable care for people with disabilities. , focused on the potential of AI to augment an already burdened workforce. “We absolutely have to improve… AI can look at entire populations to develop insights about where the healthcare system is not satisfying us so we can do more. We can reallocate the healthcare system to
Barzilay criticized the conspicuous absence of AI in healthcare today, referring to the Anti-Surprise Act enacted last year that requires insurers to be transparent in their billing codes. “The FDA has approved over 500 AI tools in the last few years, but only 10 of the 500 models have a billing code associated with them that are actually in use,” she said. . “What this shows us is that AI outcomes for patients are actually limited. We hope to bring together biotech people who translate innovations into products.” Through this forum, we have a chance to change that. ”
Despite their enthusiasm, the speakers did not superficially describe potential risks or downplay the importance of safety in the development and implementation of clinical AI tools.
“There are those who think AI will solve all the world’s problems in healthcare, replace the world’s doctors, and revolutionize healthcare. , there is also the other end of the spectrum that talks about how AI will develop its own intelligence to conquer the world,” said MIT Professor Colin, principal investigator at the Jameel Clinic, AI Cures speaker. Stolz said. “None of these concepts are new, but like most things in life, the truth lies somewhere in between.”
“There is always the possibility of unintended consequences,” said Asad Saya, CEO of the Cambridge Health Alliance and Cambridge Public Health Secretary, to the conference’s regulatory committee. ”
